Oxandrolone 10 - Livewell Pharmaceuticals

Developed in 1962 by G.D. Searle & Co., Oxandrolone was launched as Anavar, a therapeutic steroid for managing muscle-wasting conditions and growth deficiencies. Its distinct feature was a strong anabolic effect with minimal androgenic response. It was globally distributed but faced criticism as steroid use in athletics expanded. In 1989, Searle voluntarily withdrew the product. It was later reintroduced in 1995 under the name Oxandrin by Bio-Technology General Corp., granted orphan drug status for the treatment of rare disorders like HIV cachexia and pediatric growth issues.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Oxandrolone 10 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.